These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 2154462)

  • 1. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
    Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB
    J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.
    Braat EA; Collen A; Jie AF; Grimbergen JM; Rijken DC
    Biochim Biophys Acta; 2000 Sep; 1497(3):351-8. PubMed ID: 10996659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
    Hajjar KA; Hamel NM
    J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.
    Booyse FM; Lin PH; Traylor M; Bruce R
    J Biol Chem; 1988 Oct; 263(29):15139-45. PubMed ID: 3170576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase binding and receptor identification in cultured endothelial cells.
    Haddock RC; Spell ML; Baker CD; Grammer JR; Parks JM; Speidel M; Booyse FM
    J Biol Chem; 1991 Nov; 266(32):21466-73. PubMed ID: 1657968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
    Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
    Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB; Vasudevan J; Henkin J; Gonias SL
    J Biol Chem; 1993 Aug; 268(22):16327-31. PubMed ID: 8393859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
    Fleury V; Lijnen HR; Anglés-Cano E
    J Biol Chem; 1993 Sep; 268(25):18554-9. PubMed ID: 8103046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
    Berkenpas MB; Quigley JP
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7768-72. PubMed ID: 1652763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.
    Schwartz BS
    J Biol Chem; 1994 Mar; 269(11):8319-23. PubMed ID: 7907591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
    Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L; Lijnen HR; Collen D; Holmes WE
    J Biol Chem; 1987 Aug; 262(22):10855-62. PubMed ID: 2956260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu).
    Lijnen HR; Van Hoef B; Nelles L; Collen D
    J Biol Chem; 1990 Mar; 265(9):5232-6. PubMed ID: 1969415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
    Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
    Fischer BE
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):39-46. PubMed ID: 1320415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM; Dewerchin M; Lijnen HR; Bernar H; Bulens F; Nelles L; Collen D
    Eur J Biochem; 1992 Apr; 205(1):139-46. PubMed ID: 1313361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D; Lijnen HR; Piérard L; de Foresta F; Demarsin E; Jacobs P; De Wilde M; Bollen A; Collen D
    J Biol Chem; 1987 Aug; 262(24):11779-84. PubMed ID: 3114253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
    Reuning U; Bang NU
    Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.